Skip to main content

Month: January 2025

Silexion Therapeutics Announces Exercise of Warrants for $3.3 Million Gross Proceeds

Cayman Islands, January 29, 2025 — Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,221,523 of the Company’s ordinary shares originally issued in January 2025 having an exercise price of $1.35 per share. The ordinary shares issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-282932). The gross proceeds to the Company from the exercise of the warrants are expected to be approximately $3.3 million, prior to deducting placement agent fees and estimated offering expenses. The offering is...

Continue reading

MEDIROM Healthcare Technologies Inc. Announces December 2024 Key Performance Indicators (KPIs)

Total Customers Served: 80,764 – Sales Per Customer: JPY 7,384 – Customer Repeat Ratio: 77.6% TOKYO, Jan. 29, 2025 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of December 2024. Data is provided for all salons for which comparable financial and customer data is available and excludes certain salons where such information is not available. Salon Operation BusinessThe following monthly KPIs provide insight into the business fundamentals and progress of the Company, updated for the month of December 2024:Sales per customer increased to JPY 7,384 in December 2024 from JPY 7,271 in the year-ago period.  Number of Salons(*1) Number of Salons with Data(*2) Total...

Continue reading

Sanofi: Information concerning the total number of voting rights and shares – December 2024

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of 2,526,245,442 €Registered office : 46, avenue de la Grande Armée – 75017 Paris – FranceRegistered at the Paris Commercial and Companies Registry under number 395 030 844DateTotal number of issued sharesNumber of real voting rights(excluding treasury shares) Theoretical number of voting rights (including treasury shares)*December 31, 2024 1,263,122,721 1,413,130,110 1,422,661,191* Pursuant to article 223-11 of the Règlement général de l’Autorité des Marchés Financiers. This...

Continue reading

Plum Acquisition Corp. IV Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on January 31, 2025

NEW YORK, NY, Jan. 29, 2025 (GLOBE NEWSWIRE) — Plum Acquisition Corp. IV. (Nasdaq: PLMKU) (the “Company”) today announced that, commencing on January 31, 2025, holders of the units (the “Units”) sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares (the “Ordinary Shares”) and warrants (the “Warrants”) included in the Units. The Ordinary Shares and Warrants received from the separated Units will trade on the Nasdaq Global Market (“Nasdaq”) under the symbols “PLMK” and “PLMKW”, respectively. Units that are not separated will continue to trade on Nasdaq under the symbol “PLMKU”. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. Holders of Units will need to have their brokers contact Continental Stock Transfer & Trust...

Continue reading

Exco Technologies Limited Announces Results for First Quarter Ended December 31, 2024

Consolidated Sales of $146.6 million compared to $156.7 million the prior year Net Income of $4.2 million EPS of $0.11 compared to $0.15 last year EBITDA of $16.7 million compared to $18.1 million the prior year quarter Quarterly dividend of $0.105 per common share to be paid March 31, 2025TORONTO, Jan. 29, 2025 (GLOBE NEWSWIRE) — Exco Technologies Limited (TSX-XTC) today announced results for its first quarter ended December 31, 2024. In addition, Exco announced a quarterly dividend of $0.105 per common share which will be paid on March 31, 2025 to shareholders of record on March 17, 2025. The dividend is an “eligible dividend” in accordance with the Income Tax Act of Canada.  Three Months EndedDecember 31(in $ thousands except per share amounts)     2024    2023  Sales $143,568   $156,710  Net income for the...

Continue reading

HII Begins Fabrication of Amphibious Transport Dock Philadelphia (LPD 32)

PASCAGOULA, Miss., Jan. 29, 2025 (GLOBE NEWSWIRE) — HII (NYSE: HII) Ingalls Shipbuilding division began fabrication of the U.S. Navy’s newest San Antonio-class amphibious transport dock Philadelphia (LPD 32) Monday. The start of fabrication signifies that the first 100 tons of steel have been cut for the ship. “From the earliest planning stages to the first cut of steel, every step of construction so far has been focused on building a capable ship for our Navy and Marine Corps partners,” said Stephen Janowski, Ingalls Shipbuilding amphibious ship program manager. “Our team is committed to continuous improvement and seeing Philadelphia built with the quality craftsmanship needed to support our nation well into the future.” Ingalls is the sole provider of LPD 17 San Antonio-class ships and has delivered LPDs 17 through 29 to date....

Continue reading

FTG Corporation (FTG) Completes New Banking Agreement

TORONTO, Jan. 29, 2025 (GLOBE NEWSWIRE) — Firan Technology Group Corporation (TSX: FTG) (OTCQX: FTGFF) (“FTG”) today announced that is has completed a new 3-year banking agreement with BMO Corporate Finance, which matures December 11, 2027, and which includes the following features:Committed revolving operating loan facility of USD $10.0M and committed revolving term credit facility of USD $10.0M Accordion facility of USD $15.0M in support of acquisitions Ancillary credit products for foreign currency hedging, precious metals hedging and credit cardsJamie Crichton, Vice President and CFO, FTG Corporation stated “The new banking agreement with BMO Corporate Finance provides FTG with improved flexibility and reduced costs to support growth of our current operations and corporate development objectives. We look forward to working...

Continue reading

Bassett Reports Fiscal Fourth Quarter Results

BASSETT, Va., Jan. 29, 2025 (GLOBE NEWSWIRE) — Bassett Furniture Industries, Inc. (NASDAQ: BSET) reported today its results of operations for its fourth quarter ended November 30, 2024. Q4 Consolidated Business Highlights: [FY 24 vs. FY 23, unless otherwise specified]Revenues decreased 11%. Operating income of $0.9 million, which included a $1.0 million charge related to the realization of cumulative translation losses associated with the wind-down of Noa Home Inc. and a $0.4 million restructuring charge for previously announced workforce reductions. Gross margin of 56.6%, driven primarily by improved margins in the wholesale segment. Recorded a $2.6 million tax benefit related to the capital loss associated with our cumulative investment in Noa Home Inc. in 2022. Diluted earnings per share of $0.38 vs. a loss of $0.47. Generated...

Continue reading

Raymond James Financial Reports Fiscal First Quarter of 2025 Results

ST. PETERSBURG, Fla., Jan. 29, 2025 (GLOBE NEWSWIRE) —Record quarterly net revenues of $3.54 billion, up 17% over the prior year’s fiscal first quarter and 2% over the preceding quarter Quarterly net income available to common shareholders of $599 million, or $2.86 per diluted share; quarterly adjusted net income available to common shareholders of $614 million(1), or $2.93 per diluted share(1) Client assets under administration of $1.56 trillion and record quarter-end Private Client Group assets in fee-based accounts of $876.6 billion, up 14% and 17%, respectively, over December 2023 Domestic Private Client Group net new assets(2) of $14.0 billion for the fiscal first quarter, annualized growth from beginning of period assets of 4.0% Total clients’ domestic cash sweep and Enhanced Savings Program (“ESP”) balances of $59.7...

Continue reading

Hawkins, Inc. Reports Third Quarter Fiscal 2025 Results

ROSEVILLE, Minn., Jan. 29, 2025 (GLOBE NEWSWIRE) — Hawkins, Inc. (Nasdaq: HWKN) today announced results for the nine months ended December 29, 2024, its third quarter of fiscal 2025. Third Quarter Fiscal Year 2025 Highlights:Record third quarter results for revenue, gross profit, operating income, and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a non-GAAP measure. Overall revenue growth of 8%, once again driven by the Water Treatment segment growth of 22% over the same period of the prior year. Gross profit growth of 15% over the same period of the prior year, with double-digit percentage growth for both the Water Treatment and Health and Nutrition segments. Third quarter operating income of $21.1 million, our 27th consecutive quarter of year-over-year operating income growth. Income...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.